Reference health
PTPN2 improved renal injury and fibrosis by suppressing STAT‐induced inflammation in early diabetic nephropathy
39/39 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 39 checked references that resolve
resolves10.1681/ASN.2014100989
Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease
resolves10.1001/jama.2016.10924
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
resolves10.1007/s00592-014-0603-1
Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy
resolves10.2337/db11-0751
Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy
resolves10.1681/ASN.2016020237
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy
resolves10.1016/j.kint.2017.05.013
Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism
resolves10.1038/ki.2010.263
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
resolves10.1681/ASN.2015010111
Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy
resolves10.1038/nrneph.2011.51
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
resolves10.1007/s00125-014-3413-7
Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice
resolves10.1038/mi.2014.122
PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis
resolves10.1016/j.cmet.2014.05.011
Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2
resolves10.3748/wjg.v22.i3.1034
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease
resolves10.1038/srep45077
Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development
resolves10.1002/art.39256
Protein Tyrosine Phosphatase Nonreceptor Type 2: An Important Regulator of lnterleukin‐6 Production in Rheumatoid Arthritis Synovial Fibroblasts
resolves10.1136/gut.2010.216606
Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells
resolves10.1016/j.jss.2012.06.050
The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease
resolves10.1016/j.cyto.2015.12.025
TC-PTP and PTP1B: Regulating JAK–STAT signaling, controlling lymphoid malignancies
resolves10.1172/JCI60001
Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease
resolves10.2337/db11-0518
Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE−/−/LDL Receptor−/− Mice
resolves10.1093/ajcp/28.1.56
A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases
resolves10.1038/cddis.2017.292
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
resolves10.1016/j.kint.2016.09.042
Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice
resolves10.1016/j.jaut.2016.09.004
PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity
resolves10.2337/db08-1510
PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Interferon-γ–Induced Pancreatic β-Cell Apoptosis
resolves10.1002/ibd.21325
Protein Tyrosine Phosphatase non-Receptor Type 2 regulates IFN-γ-induced cytokine signaling in THP-1 monocytes
resolves10.2337/db08-1328
Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
resolves10.1038/ki.2015.331
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress
resolves10.1152/ajprenal.00503.2010
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis
resolves10.1007/s00125-017-4322-3
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
resolves10.2337/db05-1367
2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice
resolves10.1186/s13098-015-0097-1
Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/jcmm.14304"><img src="https://citestamp.com/citestamped/10.1111/jcmm.14304/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/jcmm.14304)